ArticleDiscover oncology2025

Identification of DCAF5 as a novel cancer prognostic and immunotherapy biomarker through pan-cancer analysis and renal clear cell carcinoma clinical data validation.

Huaqing Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.